EP0747351A3 - Thiokationische Lipide, pharmazeutische Zusammensetzungen und ihre Anwendungsmethoden - Google Patents
Thiokationische Lipide, pharmazeutische Zusammensetzungen und ihre Anwendungsmethoden Download PDFInfo
- Publication number
- EP0747351A3 EP0747351A3 EP96304227A EP96304227A EP0747351A3 EP 0747351 A3 EP0747351 A3 EP 0747351A3 EP 96304227 A EP96304227 A EP 96304227A EP 96304227 A EP96304227 A EP 96304227A EP 0747351 A3 EP0747351 A3 EP 0747351A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- pharmaceutical compositions
- thiocationic lipids
- thiocationic
- lipids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/543—Lipids, e.g. triglycerides; Polyamines, e.g. spermine or spermidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
- C07C381/12—Sulfonium compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US480622 | 1983-03-30 | ||
| US48020395A | 1995-06-07 | 1995-06-07 | |
| US482305 | 1995-06-07 | ||
| US480203 | 1995-06-07 | ||
| US482430 | 1995-06-07 | ||
| US08/482,497 US5739271A (en) | 1995-06-07 | 1995-06-07 | Thiocationic lipids |
| US08/482,430 US5759519A (en) | 1995-06-07 | 1995-06-07 | Method for the intracellular delivery of biomolecules using thiocationic lipids |
| US08/480,204 US5756352A (en) | 1995-06-07 | 1995-06-07 | Thiocationic lipid-nucleic acid conjugates |
| US08/480,622 US5711964A (en) | 1995-06-07 | 1995-06-07 | Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D |
| US08/482,305 US5851548A (en) | 1995-06-07 | 1995-06-07 | Liposomes containing cationic lipids and vitamin D |
| US480204 | 1995-06-07 | ||
| US482497 | 1995-06-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP0747351A2 EP0747351A2 (de) | 1996-12-11 |
| EP0747351A3 true EP0747351A3 (de) | 1997-02-26 |
Family
ID=27560046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP96304227A Withdrawn EP0747351A3 (de) | 1995-06-07 | 1996-06-06 | Thiokationische Lipide, pharmazeutische Zusammensetzungen und ihre Anwendungsmethoden |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0747351A3 (de) |
| JP (1) | JPH11507031A (de) |
| KR (1) | KR19990022597A (de) |
| AU (1) | AU5862296A (de) |
| CA (1) | CA2222586A1 (de) |
| WO (1) | WO1996040627A2 (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6350853B1 (en) | 1993-04-26 | 2002-02-26 | Peter E. Nielsen | Conjugated peptide nucleic acids having enhanced cellular uptake |
| CA2237316C (en) | 1995-11-30 | 2012-06-26 | Vical Incorporated | Complex cationic lipids |
| EP1049793B1 (de) | 1998-01-30 | 2005-10-12 | Aventis Pharma S.A. | Für reduzierende bedingungen empfindliche transfektions-verbindungen, pharmazeutische zusammensezungen die diese enthalten und deren verwendung. |
| US6242188B1 (en) | 1999-07-30 | 2001-06-05 | Applied Gene Technologies, Inc. | Sample processing to release nucleic acids for direct detection |
| WO2002014548A1 (en) * | 2000-08-10 | 2002-02-21 | Applied Gene Technologies, Inc. | Compositions and methods for nucleic acids sample processing and amplification |
| DE10064870B4 (de) * | 2000-12-27 | 2004-10-07 | G.O.T. Gesellschaft Zur Therapieoptimierung Und Targeting Entwicklungs Mbh | Schwefelhaltige Amphiphile für den Transfer von biologisch aktiven Molekülen in Zellen |
| EP2857043B1 (de) | 2012-05-31 | 2019-01-23 | Terumo Kabushiki Kaisha | Ph-empfindlicher träger und verfahren zur herstellung davon, ph-empfindliches arzneimittel und ph-empfindliche pharmazeutische zusammensetzung mit diesem träger sowie kulturverfahren unter verwendung des besagten ph-empfindlichen arzneimittels oder der besagten ph-empfindlichen pharmazeutischen zusammensetzung |
| CN105037491A (zh) | 2015-06-04 | 2015-11-11 | 大连民族学院 | 一类丙烷基阳离子肽脂质及其合成方法和应用 |
| CN107281106B (zh) * | 2017-06-21 | 2020-08-04 | 吉林大学 | 胆酸盐修饰的阳离子维生素d3口服脂质体及其冻干制剂 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| WO1990010448A2 (en) * | 1989-03-07 | 1990-09-20 | Genentech, Inc. | Covalent conjugates of lipid and oligonucleotide |
| WO1991016024A1 (en) * | 1990-04-19 | 1991-10-31 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
| WO1995017373A1 (en) * | 1993-12-20 | 1995-06-29 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
-
1996
- 1996-05-17 JP JP9500592A patent/JPH11507031A/ja active Pending
- 1996-05-17 WO PCT/US1996/007121 patent/WO1996040627A2/en not_active Ceased
- 1996-05-17 AU AU58622/96A patent/AU5862296A/en not_active Abandoned
- 1996-05-17 CA CA002222586A patent/CA2222586A1/en not_active Abandoned
- 1996-05-17 KR KR1019970709078A patent/KR19990022597A/ko not_active Withdrawn
- 1996-06-06 EP EP96304227A patent/EP0747351A3/de not_active Withdrawn
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897355A (en) * | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| WO1990010448A2 (en) * | 1989-03-07 | 1990-09-20 | Genentech, Inc. | Covalent conjugates of lipid and oligonucleotide |
| US5100662A (en) * | 1989-08-23 | 1992-03-31 | The Liposome Company, Inc. | Steroidal liposomes exhibiting enhanced stability |
| WO1991016024A1 (en) * | 1990-04-19 | 1991-10-31 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| WO1995017373A1 (en) * | 1993-12-20 | 1995-06-29 | Life Technologies, Inc. | Highly packed polycationic ammonium, sulfonium and phosphonium lipids |
Non-Patent Citations (3)
| Title |
|---|
| A. ELGAVISH ET AL, J. MEMBRANE BIOL., vol. 72, 1983, pages 85 - 91, XP000196352 * |
| M.J. BENNETT ET AL, BIOSCI. REP., vol. 15, no. 1, 1995, pages 47 - 53, XP000196643 * |
| S.L. MORRIS-NATSCHKE ET AL, J. MED. CHEM., vol. 36, no. 14, 1993, pages 2018 - 2025, XP000196342 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH11507031A (ja) | 1999-06-22 |
| EP0747351A2 (de) | 1996-12-11 |
| AU5862296A (en) | 1996-12-30 |
| KR19990022597A (ko) | 1999-03-25 |
| WO1996040627A2 (en) | 1996-12-19 |
| WO1996040627A3 (en) | 1997-02-13 |
| CA2222586A1 (en) | 1996-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA26553A1 (fr) | Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la | |
| BR9610153A (pt) | Formulações farmacêuticas | |
| BR9601032A (pt) | Micropartícula e formulação de vacina de dose única | |
| HUS1200028I1 (hu) | 4"-Szubsztituált-9-dezoxo-9a-aza-9a-homoeritromicin-származékok és ezeket tartalmazó gyógyszerek | |
| DE19681287T1 (de) | Orale Formulierung von 2-Methylthienobenzodiazepin | |
| EP0841932A4 (de) | Verbesserte drogenverabreichung durch modifizierte saponine | |
| DZ2494A1 (fr) | Composition pharmaceutique d'oméprazole. | |
| FI973278A7 (fi) | Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| MA26507A1 (fr) | Compositions pharmaceutiques d'aerosol | |
| BR9607851B1 (pt) | combinaÇço e formulaÇço farmacÊutica. | |
| ATE243516T1 (de) | Amoxicillin und clavulanat enthaltende arzneizubereitungen | |
| NO981008D0 (no) | Farmasöytisk formulering | |
| EP0652770A4 (de) | Orale gabe von antigenen. | |
| EP0830357A4 (de) | Radiosensibilisierende diamine und pharmazeutische zubereitungen davon | |
| TR199600499A2 (tr) | S(+)-Etodolak'in oral formülasyonlari. | |
| EP0850057A4 (de) | Pharmazeutische zusammensetzungen | |
| FR2753376B1 (fr) | Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques | |
| FI950458A7 (fi) | N-(3-aminopropyyli)-N-fenyyli-5,6,7,8-tetrahydronaftalen-2-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö | |
| FR2731706B1 (fr) | Composes heterocycliques aromatiques, compositions pharmaceutiques et cosmetiques les contenant et utilisations | |
| DZ1926A1 (fr) | Formulations pharmaceutiques. | |
| MA26434A1 (fr) | Composes n-alkylfuranne-nitrone et leur utilisation en tant q'agents pharmaceutiques | |
| FR2771093B1 (fr) | Derives d'imidazole, leur preparation et leur application en therapeutique | |
| FI964900A7 (fi) | Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet | |
| IL118385A0 (en) | Styryl benzimidazole derivatives and pharmaceutical compositions containing them | |
| FR2779429B1 (fr) | Derives d'oxindole, leurs preparations et leurs applications en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
| PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
| AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE |
|
| 17P | Request for examination filed |
Effective date: 19970806 |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GEN-PROBE INCORPORATED |
|
| 17Q | First examination report despatched |
Effective date: 19981005 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19990416 |